×
Wednesday, May 13, 2026

Nevada to receive $1.7M in settlement with pharmaceutical for fraudulent Medicaid claims - Carson Now

Nevada will receive $1.7 million as part of a settlement reached among all 50 states with Mallinckrodt ARD, LLC, formerly known as Questcor Pharmaceuticals, Inc. in a case alleging fraudulent Medicaid claims, according to the state's Attorney General's office.

On June 16, Nevada Attorney General Aaron Ford announced terms of the $233.7 million settlement, joined by all 50 states, Washington, D.C., Puerto Rico and the federal government, that will be paid over a period of seven years. In total, Nevada will receive $1,703,095 from the settlement.

“My office will not stop going after those who would seek to defraud our state and our healthcare and Medicaid system,” said Ford. “I would like to thank the office’s Medicaid Fraud Control Unit for the vital work they do — this is just the latest win they have delivered for the state of Nevada.”

The following is from a news release from the Nevada Attorney General's Office:

The settlement resolves allegations that from Jan. 1, 2013, through June 30, 2020, Mallinckrodt knowingly underpaid Medicaid rebates due for its drug H.P. Acthar Gel (Acthar). The government alleges that Mallinckrodt’s conduct violated the Federal False Claims Act and the Nevada False Claims Act and resulted in the submission of false claims to the Nevada Medicaid program.

Under the Medicaid Drug Rebate Program, when a manufacturer increases the price of a drug faster than the rate of inflation, it must pay the Medicaid program a per-unit rebate of the...



Read Full Story: https://carsonnow.org/story/06/19/2022/nevada-receive-17m-settlement-pharmace...